ArticleCancer immunology, immunotherapy : CII2015

Preclinical activity of anti-CCR7 immunotherapy in patients with high-risk chronic lymphocytic leukemia.

Carlos Cuesta-Mateos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.